Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Yezan M. Salamoun"'
Publikováno v:
Future Pharmacology, Vol 2, Iss 4, Pp 625-641 (2022)
Although methotrexate (MTX) is the first line disease-modifying therapy used in the treatment of autoimmune arthritis, it is limited by its unpredictable and variable response profile and lack of therapeutic biomarkers to predict or monitor therapeut
Externí odkaz:
https://doaj.org/article/c00b1c984ae94afc8b260018eb578b91
Publikováno v:
Metabolites, Vol 12, Iss 1, p 24 (2021)
Methotrexate (MTX) is widely used in the treatment of autoimmune arthritis but is limited by its unpredictable and variable response profile. Currently, no biomarkers exist to predict or monitor early therapeutic responses to MTX. Using a collagen-in
Externí odkaz:
https://doaj.org/article/ddc0a2caa5054cf7ae67f9f52aa01b96